At some point, research becomes a way to avoid making a decision and you deserve better than staying stuck
In the LEADER trial, over 9,340 patients with type 2 diabetes and high cardiovascular disease risk underwent randomization to liraglutide or placebo and were followed for a median of 3.8 years resulting in a 13% risk reduction in a combined endpoint of death from cardiovascular cause, nonfatal myocardial infarction, or nonfatal stroke [46]
Unit-to-milligram conversion at 5.0 mg/mL (1.0 mL water) If you chose the more concentrated option of 1.0 mL water, each unit on your syringe contains twice as much semaglutide compared to the 2.5 mg/mL setup
Current treatment strategies and nanocarrier based approaches for the treatment and management of diabetic retinopathy
Its the drink that says, Hey, Ive got your backand your muscles!* So, pop open a can, take a sip, and join the revolution